Location
Cambridge, USA
CEO
John Quisel, JD, PhD
Website
Social
Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercialising novel treatments for patients who suffer from serious haematological diseases. They are building a portfolio of innovative, first-in-class therapeutic candidates that aim to address a wide spectrum of haematological diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis.
Keep browsing through the other companies in our portfolio.